Primary study · included by 1 review
ZIF-8 induced hydroxyapatite-like crystals enabled superior osteogenic ability of MEW printing PCL scaffolds
B. Wang 2023 · Wang Bingqian, Zeng Yuyang, Liu Shaokai, et al. · Journal of Nanobiotechnology · 2023
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | QM = 0.163, df = 3, p = 0.983, R2 = 0% | 16 studies | GRADE not reported |
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | QM = 0.01, df = 1, p = 0.922, R2 = 0% | 16 studies | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | QM = 9.509, df = 3, p = 0.023, R2 = 28.8% | 20 studies | GRADE not reported |
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | Meta-regression beta (difference in MD, %) -0.646 [-15.869, 14.577] | 16 studies | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | Meta-regression beta (difference in MD, %) 0.853 [-4.49, 6.195] | 20 studies | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | MD 1.68 [0.34, 3.03] | 18 studies · 194 participants | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | Meta-regression beta (difference in MD, %) -4.258 [-8.216, -0.3] | 20 studies | GRADE not reported |
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | QM = 0.099, df = 1, p = 0.753, R2 = 0% | 16 studies | GRADE not reported |
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | MD 2.22 [-1.36, 5.8] | 15 studies · 122 participants | GRADE not reported |
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | Meta-regression beta (difference in MD, %) -0.556 [-15.803, 14.691] | 16 studies | GRADE not reported |
Bone regeneration (BV/TV, %) after 2 months (late stage, 3 months) Polycaprolactone (PCL)-only scaffold vs Empty defect · After 2 months (late; 3 months) | Meta-regression beta (difference in MD, %) 1.527 [-6.989, 10.044] | 16 studies | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | QM = 0.703, df = 1, p = 0.402, R2 = 0% | 20 studies | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | Meta-regression beta (difference in MD, %) -6.987 [-12.867, -1.108] | 20 studies | GRADE not reported |
Bone regeneration (BV/TV, %) at one month (early stage) Polycaprolactone (PCL)-only scaffold vs Empty defect · 1 month (early; includes follow-up up to 1 month) | QM = 0.334, df = 1, p = 0.563, R2 = 0% | 20 studies | GRADE not reported |
1 including review in total.